These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 2554972)
1. Type I collagen degradation by mouse calvarial osteoblasts stimulated with 1,25-dihydroxyvitamin D-3: evidence for a plasminogen-plasmin-metalloproteinase activation cascade. Thomson BM; Atkinson SJ; McGarrity AM; Hembry RM; Reynolds JJ; Meikle MC Biochim Biophys Acta; 1989 Nov; 1014(2):125-32. PubMed ID: 2554972 [TBL] [Abstract][Full Text] [Related]
2. Degradation of type I collagen films by mouse osteoblasts is stimulated by 1,25 dihydroxyvitamin D3 and inhibited by human recombinant TIMP (tissue inhibitor of metalloproteinases). Thomson BM; Atkinson SJ; Reynolds JJ; Meikle MC Biochem Biophys Res Commun; 1987 Oct; 148(2):596-602. PubMed ID: 2825666 [TBL] [Abstract][Full Text] [Related]
3. Bone-derived growth factors modulate collagenase and TIMP (tissue inhibitor of metalloproteinases) activity and type I collagen degradation by mouse calvarial osteoblasts. Meikle MC; McGarrity AM; Thomson BM; Reynolds JJ Bone Miner; 1991 Jan; 12(1):41-55. PubMed ID: 1848130 [TBL] [Abstract][Full Text] [Related]
4. Human osteoblasts in culture synthesize collagenase and other matrix metalloproteinases in response to osteotropic hormones and cytokines. Meikle MC; Bord S; Hembry RM; Compston J; Croucher PI; Reynolds JJ J Cell Sci; 1992 Dec; 103 ( Pt 4)():1093-9. PubMed ID: 1336777 [TBL] [Abstract][Full Text] [Related]
5. ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade. Baricos WH; Cortez SL; el-Dahr SS; Schnaper HW Kidney Int; 1995 Apr; 47(4):1039-47. PubMed ID: 7540230 [TBL] [Abstract][Full Text] [Related]
6. Gingival fibroblasts degrade type I collagen films when stimulated with tumor necrosis factor and interleukin 1: evidence that breakdown is mediated by metalloproteinases. Meikle MC; Atkinson SJ; Ward RV; Murphy G; Reynolds JJ J Periodontal Res; 1989 May; 24(3):207-13. PubMed ID: 2550604 [TBL] [Abstract][Full Text] [Related]
8. Co-operation between interleukin-1 and the fibrinolytic system in the degradation of collagen by articular chondrocytes. Cruwys SC; Davies DE; Pettipher ER Br J Pharmacol; 1990 Jul; 100(3):631-5. PubMed ID: 2167739 [TBL] [Abstract][Full Text] [Related]
9. Activation of gelatinases by fibrin is PA/plasmin system-dependent in human glomerular endothelial cells. Cai G; Chen X; Fu B; Lu Y Mol Cell Biochem; 2005 Sep; 277(1-2):171-9. PubMed ID: 16132729 [TBL] [Abstract][Full Text] [Related]
10. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. HE CS; Wilhelm SM; Pentland AP; Marmer BL; Grant GA; Eisen AZ; Goldberg GI Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2632-6. PubMed ID: 2468156 [TBL] [Abstract][Full Text] [Related]
11. Immunolocalization of metalloproteinases and their inhibitor in the rabbit growth plate. Brown CC; Hembry RM; Reynolds JJ J Bone Joint Surg Am; 1989 Apr; 71(4):580-93. PubMed ID: 2539384 [TBL] [Abstract][Full Text] [Related]
12. In vitro effects of interleukin 1 on the synthesis of metalloproteases, TIMP, plasminogen activators and inhibitors in human articular cartilage. Martel-Pelletier J; Zafarullah M; Kodama S; Pelletier JP J Rheumatol Suppl; 1991 Feb; 27():80-4. PubMed ID: 1851231 [TBL] [Abstract][Full Text] [Related]
13. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system. Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of bone resorption in vitro by selective inhibitors of gelatinase and collagenase. Hill PA; Docherty AJ; Bottomley KM; O'Connell JP; Morphy JR; Reynolds JJ; Meikle MC Biochem J; 1995 May; 308 ( Pt 1)(Pt 1):167-75. PubMed ID: 7755562 [TBL] [Abstract][Full Text] [Related]
15. Cell-mediated degradation of type IV collagen and gelatin films is dependent on the activation of matrix metalloproteinases. Atkinson SJ; Ward RV; Reynolds JJ; Murphy G Biochem J; 1992 Dec; 288 ( Pt 2)(Pt 2):605-11. PubMed ID: 1463464 [TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alpha stimulates the biosynthesis of matrix metalloproteinases and plasminogen activator in cultured human chorionic cells. So T; Ito A; Sato T; Mori Y; Hirakawa S Biol Reprod; 1992 May; 46(5):772-8. PubMed ID: 1317222 [TBL] [Abstract][Full Text] [Related]
17. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. Mazzieri R; Masiero L; Zanetta L; Monea S; Onisto M; Garbisa S; Mignatti P EMBO J; 1997 May; 16(9):2319-32. PubMed ID: 9171346 [TBL] [Abstract][Full Text] [Related]
18. The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts. Hill PA; Murphy G; Docherty AJ; Hembry RM; Millican TA; Reynolds JJ; Meikle MC J Cell Sci; 1994 Nov; 107 ( Pt 11)():3055-64. PubMed ID: 7699005 [TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta regulation of collagenase, 72 kDa-progelatinase, TIMP and PAI-1 expression in rat bone cell populations and human fibroblasts. Overall CM; Wrana JL; Sodek J Connect Tissue Res; 1989; 20(1-4):289-94. PubMed ID: 2558843 [TBL] [Abstract][Full Text] [Related]